NOS3 and endothelial dysfunction: This not only reduces the bioactivity of NO but also oxidizes the crucial cofactor tetrahydrobiopterin (BH4) of eNOS into dihydrobiopterin (BH2), causing eNOS uncoupling and an increase in O2− production, ultimately leading to endothelial dysfunction [59].